Aptima HR-HPV Testing of Cytology Specimens Is an Effective Supplement for p16 Staining to Improve Diagnostic Accuracy for HPV-Related Oropharyngeal Squamous Cell Carcinoma

被引:2
|
作者
Yang, Xin [1 ]
Hu, Chunfang [1 ]
Zhao, Huan [1 ]
Zhang, Zhihui [1 ]
Zhao, Linlin [1 ]
Yu, Jing [2 ]
Ni, Xiaoguang [3 ]
Guo, Huiqin [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Dept Pathol, Natl Canc Ctr,Canc Hosp, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Hebei Canc Hosp, Natl Canc Ctr, Dept Pathol,Natl Clin Res Ctr Canc, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Endoscopy,Natl Clin Res Ctr Canc, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Oropharyngeal squamous cell carcinoma; Human papilloma virus; Aptima; p16; Brush cytology; E6/E7; MESSENGER-RNA; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; ORAL-CAVITY; HEAD; RISK; SURVIVAL;
D O I
10.1159/000527951
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Introduction: Regarding a small proportion of oropharyngeal squamous cell carcinoma (OPSCC) patients who tested p16-positive but human papillomavirus (HPV)-negative, we attempted to perform HPV testing to improve the accuracy of HPV detection in OPSCC patients. Methods: We simultaneously performed Aptima HPV testing of cytological specimens and p16 immunohistochemistry (IHC) staining of histologic biopsies from the same cohort of patients with head and neck SCC (HNSCC). The cytological specimens included fine-needle aspiration specimens from patients with enlarged nodes and endoscopic brushing specimens from the primary lesions of patients without enlarged nodes. Cases with discordant results for p16 IHC staining and Aptima HPV testing were reexamined by a third method, RNAscope testing. Results: Sixty patients with HNSCC (39 OPSCC and 21 non-OPSCC) were recruited for examination of HPV status. Among these patients, 28 were p16+/HPV+, 29 were p16-/HPV-, 2 were p16+/HPV-, and 1 was p16-/HPV+. The overall concordance rate between Aptima HPV testing and p16 IHC was 95.0%. Three cases with discordant results for these two methods were reexamined by RNAscope testing, and all were confirmed to be HPV negative. The prevalence of HPV in OPSCC and non-OPSCC patients was 61.5% (24/39) and 19.0% (4/21), respectively. The sensitivity and negative predictive values of Aptima HPV testing and p16 IHC were consistent at 100%, while the specificity and positive predictive values were 96.9% and 96.6% versus 93.8% and 93.3%, respectively. Additionally, 30 OPSCCs were simultaneously examined and diagnosed by both brush cytology and biopsy pathology; six of these SCCs were underdiagnosed by histopathology but accurately diagnosed by supplemental brush cytology. Conclusion: Aptima HPV testing of cytology specimens can be used as an adjuvant examination to identify false-positive OPSCC patients after p16 IHC of biopsies, while brush cytology may be a supplemental method for the histologic diagnosis of malignant oropharyngeal tumors.
引用
收藏
页码:321 / 331
页数:11
相关论文
共 50 条
  • [41] Expression and Diagnostic Implication of HPV and p16 in Squamous Cell Carcinoma in Multiple Organ Sites.
    Asojo, O.
    Wikenheiser-Brokamp, K.
    Hill, G.
    Lucas, F.
    Hackett, C.
    Zhai, Q. J.
    LABORATORY INVESTIGATION, 2011, 91 : 405A - 405A
  • [42] The discordant biomarker dilemma: What are the diagnostic implications of oropharyngeal squamous cell carcinomas with discrepant p16 and HPV results?
    Guzman-Arocho, Yaileen D.
    Nishino, Michiya
    CANCER CYTOPATHOLOGY, 2022, 130 (11) : 844 - 848
  • [43] Detection of cfHPV16-DNA in liquid biopsy - A promising biomarker for patients with HPV-related oropharyngeal squamous cell carcinoma
    Wuerdemann, Nora
    Alidousty, Christina
    Siefer, Oliver
    Jain, Rishabh
    Huebbers, Christian Ulrich
    Silling, Steffi
    Schafigh, Darius
    Bacher, Robin
    Reder, Henrike
    Buettner, Reinhard
    Dietlein, Markus
    Drzezga, Alexander
    Schlamann, Marc
    Wieland, Ulrike
    Quaas, Alexander
    Wittekindt, Claus
    Speel, Ernst-Jan
    Wagner, Steffen
    Schultheis, Anne
    Klussmann, Jens Peter
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 13 - 14
  • [44] TNM 8 staging system beyond p16: Double HPV/p16 status is superior to p16 alone in predicting outcome in oropharyngeal squamous cell carcinoma
    von Buchwald, Christian
    Jakobsen, Kathrine Kronberg
    Carlander, Amanda-Louise Fenger
    Tous, Sara
    Gronhoj, Christian
    Rasmussen, Jacob H.
    Brooks, Jill
    Taberna, Miren
    Mena, Marisa
    Morey, Francisca
    Bruni, Laia
    Batis, Nikolaos
    Brakenhoff, Ruud H.
    Leemans, C. Rene
    de Jong, Robert J. Baatenburg
    Klussmann, Jens Peter
    Wuerdemann, Nora
    Wagner, Steffen
    Dalianis, Tina
    Marklund, Linda
    Mirghani, Haitham
    Schache, Andrew
    James, Jaqueline A.
    Huang, Shao Hui
    O'Sullivan, Brian
    Nankivell, Paul
    Broglie, Martina A.
    Hoffmann, Markus
    Quabius, Elgar Susanne
    Anderson, Lesley A.
    Craig, Stephanie G.
    Alemany, Laia
    Mehanna, Hisham
    EUROPEAN JOURNAL OF CANCER, 2024, 211
  • [45] Truth or myth: Definitive chemoradiotherapy doesn't work for HPV/p16 negative oropharyngeal squamous cell carcinoma?
    Chera, Bhisham
    Wang, Kyle
    Monroe, Alan
    Galloway, Tom
    Amdur, Robert
    Hayes, D. Neil
    Zevallos, Jose
    Mendenhall, William M.
    ORAL ONCOLOGY, 2017, 65 : 125 - 126
  • [46] p16 overexpression and Rb loss correlate with high-risk HPV infection in oropharyngeal squamous cell carcinoma
    Jiromaru, Rina
    Yamamoto, Hidetaka
    Yasumatsu, Ryuji
    Hongo, Takahiro
    Nozaki, Yui
    Nakano, Takafumi
    Hashimoto, Kazuki
    Nakagawa, Takashi
    Oda, Yoshinao
    HISTOPATHOLOGY, 2021, 79 (03) : 358 - 369
  • [47] Added value of HPV-DNA in situ hybridization as an adjunct to p16 Immunohistochemistry in oropharyngeal squamous cell carcinoma
    Nissi, Linda
    Huusko, Teemu
    Routila, Johannes
    Vaittinen, Samuli
    Leivo, Ilmo
    Irjala, Heikki
    Ventela, Sami
    ACTA OTO-LARYNGOLOGICA, 2025,
  • [48] Metastatic HPV-Associated Oropharyngeal Versus Primary Pulmonary Squamous Cell Carcinoma: is p16 Immunostain Useful?
    Schulte, Jefree J.
    Steinmetz, Jamie
    Furtado, Larissa, V
    Husain, Aliya N.
    Lingen, Mark W.
    Cipriani, Nicole A.
    HEAD & NECK PATHOLOGY, 2020, 14 (04): : 966 - 973
  • [49] Association of HPV infection, p16 status, and efficacy of radiotherapy with or without cetuximab in advanced oropharyngeal squamous cell carcinoma
    Nieder, Carsten
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 (12) : 959 - 960
  • [50] Metastatic HPV-Associated Oropharyngeal Versus Primary Pulmonary Squamous Cell Carcinoma: is p16 Immunostain Useful?
    Jefree J. Schulte
    Jamie Steinmetz
    Larissa V. Furtado
    Aliya N. Husain
    Mark W. Lingen
    Nicole A. Cipriani
    Head and Neck Pathology, 2020, 14 : 966 - 973